In vivo studies in rodents showed that topical, inhalant or intratracheal applied TiO2 NPs alone worsened atopic dermatitis, induced lung injury (Interleukin-4 (IL-4) independent) and T helper-dependent inflammatory responses through ROS production and apoptosis. Here, IL4 is linked to atopic eczema.